A Review on Management of Varius Disease by Traditional Chinese Medicine Ganoderma lucidum

Author:

Rahangdale Poonam1,Wankhade A. M.1,Vyas J. V.1,Paithnakar V. V.1

Affiliation:

1. Department of Pharmacology, Vidyabharti Collage of Pharmacy Amravati, Maharastra, 444602, India.

Abstract

Traditional Chinese medicine has used also known as "Lingzhi or Reishi," for more than 2000 years for its superior therapeutic activity, including its antitumor, antiallergenic, antiviral, hepatoprotective, antioxidant, immunomodulator, hypotensive, hypoglycaemic, anti-inflammatory, antithrombotic, antibacterial, and many other health benefits. G. lucidum has recently been under scientific study to see how many bioactive components it has that have an impact on human physiology. It has also been used to make powerful components for the pharmacology, nutraceuticals, and cosmetics sectors. For instance, mounting data suggests that this particular species of mushroom may be an effective antiviral drug for the treatment of a variety of viral infections, including enterovirus 71, dengue virus, and most recently coronavirus disease of 2019. (COVID-19). One of the oldest herbal remedies, Ganoderma lucidum grows in a wide range of places on deciduous trees (dead/dying trees). Adenosine, phenols, steroids, amino acids, lignin, vitamins, nucleotides, and nucleosides are among the 400 primary bioactive chemical components that it also includes. Polysaccharides, triterpenoids, polysaccharide-peptide complex, -glucans, lectins, and natural germanium (Ge) are all included. derived from Ganoderma fruiting bodies, mycelia, which also provide a wide range of useful medicinal qualities. However, we reviewed and described in this paper about pharmacological mechanisms for treating numerous disorders in relation to Ganoderma lucidum extract (polysaccharide and triterpenoid).

Publisher

A and V Publications

Subject

General Medicine

Reference32 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3